Immuron (IMRN) Revenue (2016 - 2024)
Immuron (IMRN) posted quarterly Revenue of $8.0 million for Q4 2024, up 237.86% year-over-year from $2.4 million in Q1 2024, and up 237.86% quarter-over-quarter from $2.4 million in Q4 2023.
Immuron (IMRN) Revenue (2016 - 2024) Analysis & Trends
Immuron's Revenue history runs 9 years deep, the most recent figure standing at $8.0 million for Q4 2024.
- In Q4 2024, Revenue rose 237.86% year-over-year to $8.0 million; the TTM figure through Dec 2024 stood at $11.0 million (down 99.35% YoY), while the FY2025 annual figure was $4.7 million, up 46.88% from the prior year.
- Revenue for Q4 2024 stood at $8.0 million, up from $2.4 million in the prior quarter.
- The five-year high for Revenue was $1.7 billion in Q4 2021, with the low at $0.01 in Q4 2020.
- The 5-year median for Revenue is $1.5 million (2022), against an average of $283.6 million.
- The sharpest annual moves came in 2020 and 2021: Revenue tumbled 100.0% in 2020, then jumped 11516195763979.44% in 2021.
- Immuron's Revenue stood at $0.01 in 2020, then jumped by 11516195763979.44% to $1.7 billion in 2021, then plunged by 99.97% to $583646.0 in 2022, then surged by 303.6% to $2.4 million in 2023, then surged by 237.86% to $8.0 million in 2024.
- Business Quant data shows IMRN's Revenue at $8.0 million in Q4 2024, $2.4 million in Q4 2023, and $82942.2 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Immuron | 6.81 Mn | 6.78 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 7.96 Mn |
| Dec 31, 2023 | 2.36 Mn |
| Jun 30, 2023 | 82,942.19 |
| Dec 31, 2022 | 583,646.00 |
| Dec 31, 2021 | 1.69 Bn |
| Dec 31, 2020 | 0.01 |
| Dec 31, 2019 | 15,566.23 |
| Dec 31, 2018 | 978,233.00 |
| Dec 31, 2017 | 716,323.37 |
| Dec 31, 2016 | 530,121.20 |
| Jun 30, 2016 | 862,831.81 |